Pages

Search This Blog

Friday, December 12, 2014

Global Health Ebola Update

EBOLA

Vaccine Trial Temporarily Halted
Complaints of joint pain from several volunteers brought a clinical Ebola vaccine trial in Geneva to a temporary halt.

This is a precautionary step, not a setback, according to Marie-Paule Kieny of the WHO.  The trial will resume in early January after investigators have a chance to determine the scope of the problems and make sure the symptoms are "benign and temporary," according to the University of Geneva Hospital.

59 volunteers have been vaccinated so far in the trial of the vaccine, developed by Merck and NewLink. Separately, safety data from a trial of a GlaxoSmithKline Ebola vaccine on 120 volunteers has been satisfactory.

GAVI, the global vaccines alliance, stated its commitment to buy Ebola vaccines as soon as they’re ready, pledging $300 million.
** Reuters (http://jhsph.us3.list-manage1.com/track/click?u=0a43ad874dbe00d8f0545cfef&id=d32b8cd36a&e=9c1fcebfa3)

Related: Red Cross urges vigilance to avert holiday spike in Ebola cases – ** Reuters (http://jhsph.us3.list-manage1.com/track/click?u=0a43ad874dbe00d8f0545cfef&id=5f1056d749&e=9c1fcebfa3)

Related: Ebola in Liberia: Outbreak contained in Lofa County, MSF hands over activities – ** H5N1 (http://jhsph.us3.list-manage.com/track/click?u=0a43ad874dbe00d8f0545cfef&id=28bc39005b&e=9c1fcebfa3)


Related: Ebola in Africa: beyond epidemics, reproductive health in crisis – ** The Lancet (http://jhsph.us3.list-manage.com/track/click?u=0a43ad874dbe00d8f0545cfef&id=4009e30d1b&e=9c1fcebfa3(14)62364-3/fulltext)

Related: Saudi King gives $35 million grant for Ebola fight – ** Reuters (http://jhsph.us3.list-manage.com/track/click?u=0a43ad874dbe00d8f0545cfef&id=d0c271deac&e=9c1fcebfa3)

No comments: